Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping - PubMed (original) (raw)

Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping

S Keidel et al. Mol Cell Biol. 1994 Jan.

Abstract

The pleiotropic effects of retinoic acid on cell differentiation and proliferation are mediated by two subfamilies of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). Recently the synthetic retinoid Ro 41-5253 was identified as a selective RAR alpha antagonist. As demonstrated by gel retardation assays, Ro 41-5253 and two related new RAR alpha antagonists do not influence RAR alpha/RXR alpha heterodimerization and DNA binding. In a limited trypsin digestion assay, complexation of RAR alpha with retinoic acid or several other agonistic retinoids altered the degradation of the receptor such that a 30-kDa proteolytic fragment became resistant to proteolysis. This suggests a ligand-induced conformational change, which may be necessary for the interaction of the DNA-bound RAR alpha/RXR alpha heterodimer with other transcription factors. Our results demonstrate that antagonists compete with agonists for binding to RAR alpha and may induce a different structural alteration, suggested by the tryptic resistance of a shorter 25-kDa protein fragment in the digestion assay. This RAR alpha conformation seems to allow RAR alpha/RXR alpha binding to DNA but not the subsequent transactivation of target genes. Protease mapping with C-terminally truncated receptors revealed that the proposed conformational changes mainly occur in the DE regions of RAR alpha. Complexation of RAR beta, RAR gamma, and RXR alpha, as well as the vitamin D3 receptor, with their natural ligands resulted in a similar resistance of fragments to proteolytic digestion. This could mean that ligand-induced conformational changes are a general feature in the hormonal activation of vitamin D3 and retinoid receptors.

PubMed Disclaimer

Similar articles

• Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
  Defacque H, Sévilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T. Defacque H, et al. Leukemia. 1997 Feb;11(2):221-7. doi: 10.1038/sj.leu.2400568. Leukemia. 1997. PMID: 9009084
• Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
  Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP. Kizaki M, et al. Blood. 1996 Mar 1;87(5):1977-84. Blood. 1996. PMID: 8634447
• A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
  Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P. Vivat V, et al. EMBO J. 1997 Sep 15;16(18):5697-709. doi: 10.1093/emboj/16.18.5697. EMBO J. 1997. PMID: 9312028 Free PMC article.
• [Genetic control of the development by retinoic acid].
  Mark M, Kastner P, Ghyselinck NB, Krezel W, Dupé V, Chambon P. Mark M, et al. C R Seances Soc Biol Fil. 1997;191(1):77-90. C R Seances Soc Biol Fil. 1997. PMID: 9181129 Review. French.
• Receptor-selective retinoid agonists and teratogenic activity.
  Willhite CC, Dawson MI, Reichert U. Willhite CC, et al. Drug Metab Rev. 1996 Feb-May;28(1-2):105-19. doi: 10.3109/03602539608993994. Drug Metab Rev. 1996. PMID: 8744592 Review.

Cited by

• The hepatic Raldh1 expression is elevated in Zucker fatty rats and its over-expression introduced the retinal-induced Srebp-1c expression in INS-1 cells.
  Li Y, Zhang Y, Li R, Chen W, Howell M, Zhang R, Chen G. Li Y, et al. PLoS One. 2012;7(9):e45210. doi: 10.1371/journal.pone.0045210. Epub 2012 Sep 13. PLoS One. 2012. PMID: 23028851 Free PMC article.
• Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
  Osburn DL, Shao G, Seidel HM, Schulman IG. Osburn DL, et al. Mol Cell Biol. 2001 Aug;21(15):4909-18. doi: 10.1128/MCB.21.15.4909-4918.2001. Mol Cell Biol. 2001. PMID: 11438648 Free PMC article.
• Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.
  van den Bemd GC, Pols HA, Birkenhäger JC, van Leeuwen JP. van den Bemd GC, et al. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10685-90. doi: 10.1073/pnas.93.20.10685. Proc Natl Acad Sci U S A. 1996. PMID: 8855240 Free PMC article.
• Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha.
  Hong SH, Privalsky ML. Hong SH, et al. J Biol Chem. 1999 Jan 29;274(5):2885-92. doi: 10.1074/jbc.274.5.2885. J Biol Chem. 1999. PMID: 9915825 Free PMC article.
• Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.
  Shimono K, Tung WE, Macolino C, Chi AH, Didizian JH, Mundy C, Chandraratna RA, Mishina Y, Enomoto-Iwamoto M, Pacifici M, Iwamoto M. Shimono K, et al. Nat Med. 2011 Apr;17(4):454-60. doi: 10.1038/nm.2334. Epub 2011 Apr 3. Nat Med. 2011. PMID: 21460849 Free PMC article.

References

1. 1. Biochim Biophys Acta. 1980 Mar 12;605(1):33-91 - PubMed
2. 1. Development. 1993 May;118(1):267-82 - PubMed
3. 1. Nature. 1987 Dec 17-23;330(6149):624-9 - PubMed
4. 1. Nature. 1987 Dec 17-23;330(6149):667-70 - PubMed
5. 1. Science. 1988 May 13;240(4854):889-95 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Guide to Pharmacology

• Research Materials

  • NCI CPTC Antibody Characterization Program